CIK 0001388320 · Non-accelerated filer<br>Smaller reporting company
Actinium Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ATNM
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 880378336
- Phone
- (646) 677-3870
- Business address
- 100 PARK AVE., 23RD FLOOR, NEW YORK, NY, 10017
- Former names
- Cactus Ventures, Inc.
- 4 Returned to the company COO and Chief Medical Officer returned 2,380 shares (to the company)
- 4 Other acquisition 10% owner acquired 5,702,387 shares (other)
- 10-Q Report Quarterly Report
- 3 Insider Initial Statement of Ownership
- 4 Grant or award COO and Chief Medical Officer acquired 3,500 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 10-K Report Annual Report
- 8-K Event Bylaws or fiscal year change
- 424B5 Offering Prospectus
- 8-K Event Material agreement · Other events
- 8-K Event Other events
- 424B5 Offering Prospectus
- 8-K Event Shareholder vote results
- ARS Other Annual Report to Security Holders
- DEF 14A Proxy Proxy Statement
- 8-K Event Regulation FD disclosure
- PRE 14A Proxy Proxy Statement (Preliminary)
Page 18 of 26 · 511 filings